|
71
|
268
|
4xv1A |
B-raf kinase v600e oncogenic mutant in complex with plx7904 |
|
92
|
297
|
4xs2A |
Irak4-inhibitor co-structure |
|
107
|
346
|
4xneA |
Crystal structure of erk2 in complex with an inhibitor |
|
105
|
297
|
4y73A |
Crystal structure of irak4 kinase domain with inhibitor |
|
84
|
273
|
4xeyA |
Crystal structure of an sh2-kinase domain construct of c-abl tyrosine kinase |
|
86
|
273
|
4xg7A |
Crystal structure of an inhibitor-bound syk |
|
93
|
293
|
4xbuA |
In vitro crystal structure of pak4 in complex with inka peptide |
|
92
|
295
|
4xmoA |
Crystal structure of c-met in complex with (r)-5-(8-fluoro-3-(1-fluoro-1-(3-methoxyquinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole |
|
99
|
356
|
4y46A |
Pyridopyrimidinone derivatives as potent and selective c-jun n-terminal kinase (jnk) inhibitors |
|
100
|
343
|
4xbrA |
In cellulo crystal structure of pak4 in complex with inka |
|
98
|
303
|
4x0mA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
91
|
303
|
4v04A |
Fgfr1 in complex with ponatinib. |
|
100
|
303
|
4x2fA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
92
|
300
|
4uv0A |
Structure of a semisynthetic phosphorylated dapk |
|
89
|
302
|
4uwbA |
Fibroblast growth factor receptor 1 kinase in complex with jk-p5 |
|
77
|
269
|
4wa9A |
The crystal structure of human abl1 wild type kinase domain in complex with axitinib |
|
88
|
306
|
4w9wA |
Crystal structure of bmp-2-inducible kinase in complex with small molecule azd-7762 |
|
102
|
356
|
4w4yA |
Jnk2/3 in complex with 3-(4-{[(4-methylphenyl)carbamoyl]amino}-1h-pyrazol-1-yl)-n-(2-methylpyridin-4-yl)benzamide |
|
100
|
303
|
4x2gA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
76
|
283
|
4v0gB |
Jak3 in complex with a covalent egfr inhibitor |
|
81
|
273
|
4wt6A |
Crystal structure of human pim-1 kinase in complex with a thiadiazolamine-indole inhibitor. |
|
91
|
301
|
4uwyA |
Fgfr1 apo structure |
|
86
|
304
|
4w9xA |
Crystal structure of bmp-2-inducible kinase in complex with baricitinib |
|
75
|
287
|
4x3fA |
Crystal structure of the intracellular domain of the m. tuberculosis ser/thr kinase pkna |
|
79
|
280
|
4x3jA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
95
|
313
|
4uy9A |
Structure of mlk1 kinase domain with leucine zipper 1 |
|
76
|
282
|
4v0gA |
Jak3 in complex with a covalent egfr inhibitor |
|
96
|
326
|
4wrgA |
1.9 angstrom structure of egfr kinase domain |
|
91
|
296
|
4uxlA |
Structure of human ros1 kinase domain in complex with pf-06463922 |
|
75
|
274
|
4wo5A |
Crystal structure of a braf kinase domain monomer |
|
72
|
291
|
4usdA |
Human stk10 (lok) with sb-633825 |
|
169
|
465
|
4wg3A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1610 |
|
108
|
356
|
4whzA |
Design and synthesis of highly potent and isoform selective jnk3 inhibitors: sar studies on aminopyrazole derivatives |
|
76
|
273
|
4wsyA |
Crystal structure of human pim-1 kinase in complex with a thiazolamine-indazole inhibitor. |
|
74
|
308
|
4uyaA |
Structure of mlk4 kinase domain with atpgammas |
|
90
|
301
|
4uwcA |
Fibroblast growth factor receptor 1 kinase in complex with jk-p3 |
|
99
|
337
|
4wbbB |
Single turnover autophosphorylation cycle of the pka riib holoenzyme |
|
103
|
337
|
4x6qC |
An isoform-specific myristylation switch targets riib pka holoenzymes to membranes |
|
79
|
328
|
4wd5A |
Crystal structure of egfr 696-1022 t790m in complex with ql-x138 |
|
87
|
262
|
4uzdA |
Sar156497 an exquisitely selective inhibitor of aurora kinases |
|
117
|
370
|
4wuaA |
Crystal structure of human srpk1 complexed to an inhibitor srpin340 |
|
83
|
268
|
4uzhA |
Sar156497 an exquisitely selective inhibitor of aurora kinases |
|
91
|
327
|
4wkqA |
1.85 angstrom structure of egfr kinase domain with gefitinib |
|
106
|
331
|
4umtA |
Structure of melk in complex with inhibitors |
|
162
|
464
|
4wg5A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1647 |
|
160
|
506
|
4wboA |
Bovine g protein coupled receptor kinase 1 in complex with amlexanox |
|
98
|
290
|
4w8dA |
Crystal structure of mst3 with a pyrrolopyrimidine inhibitor (pf-06454589). |
|
81
|
290
|
4x3fB |
Crystal structure of the intracellular domain of the m. tuberculosis ser/thr kinase pkna |
|
90
|
301
|
4v01A |
Fgfr1 in complex with ponatinib (co-crystallisation). |
|
87
|
290
|
4wovA |
Crystal structure of tyrosine kinase 2 jh2 (pseudo kinase domain) complexed with bms-066 aka 2-methoxy-n-({6-[3-methyl-7-(methylamino)-3,5,8,10-tetraazatricyclo[7.3.0.0, 6]dodeca-1(9),2(6),4,7,11-pentaen-11-yl]pyridin-2-yl}methy l)acetamide |
